Chinese investors are investing heavily in US drug start-ups, adding to a flood of cash flowing to groundbreaking health firms. Pictured are US dollar and China yuan notes. Photo illustration: Reuters Chinese investors are investing heavily in US drug start-ups, adding to a flood of cash flowing to groundbreaking health firms. Pictured are US dollar and China yuan notes. Photo illustration: Reuters
Chinese investors are investing heavily in US drug start-ups, adding to a flood of cash flowing to groundbreaking health firms. Pictured are US dollar and China yuan notes. Photo illustration: Reuters
Pharmaceuticals
Business

Chinese funds pour US$1.4b into US biotechnology firms in the first three months of the year

It’s unclear whether a deepening trade rift with the US could slow the stream of cash from China to medical innovation hubs such as Silicon Valley and Cambridge, Massachusetts

Topic |   Pharmaceuticals
Bloomberg
Bloomberg

Updated: 8:40am, 19 Apr, 2018

Why you can trust SCMP
Chinese investors are investing heavily in US drug start-ups, adding to a flood of cash flowing to groundbreaking health firms. Pictured are US dollar and China yuan notes. Photo illustration: Reuters Chinese investors are investing heavily in US drug start-ups, adding to a flood of cash flowing to groundbreaking health firms. Pictured are US dollar and China yuan notes. Photo illustration: Reuters
Chinese investors are investing heavily in US drug start-ups, adding to a flood of cash flowing to groundbreaking health firms. Pictured are US dollar and China yuan notes. Photo illustration: Reuters
READ FULL ARTICLE